Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.550 | 0.550 | 0.000 |
Shares | 58.980 | 58.980 | 0.000 |
Bonds | 38.970 | 38.970 | 0.000 |
Convertible | 0.600 | 0.600 | 0.000 |
Preferred | 0.520 | 0.520 | 0.000 |
Other | 0.370 | 0.370 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.822 | 15.077 |
Price to Book | 2.072 | 2.094 |
Price to Sales | 1.167 | 1.552 |
Price to Cash Flow | 8.069 | 8.718 |
Dividend Yield | 2.003 | 2.598 |
5 Years Earnings Growth | 12.468 | 12.417 |
Name | Net % | Category Average |
---|---|---|
Technology | 26.450 | 17.340 |
Healthcare | 19.660 | 11.264 |
Industrials | 11.810 | 12.392 |
Basic Materials | 11.380 | 6.416 |
Consumer Defensive | 10.630 | 6.821 |
Financial Services | 7.280 | 16.683 |
Energy | 6.540 | 5.534 |
Consumer Cyclical | 6.250 | 12.778 |
Number of long holdings: 153
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CVS Health Corp | US1266501006 | 3.00 | 57.10 | +0.48% | |
PepsiCo | US7134481081 | 2.80 | 160.34 | +1.01% | |
Arab Rep Egypt | - | 2.76 | - | - | |
Linde PLC | IE000S9YS762 | 2.64 | 430.800 | +1.99% | |
Cisco | US17275R1023 | 2.46 | 57.56 | +0.10% | |
Exxon Mobil | US30231G1022 | 2.44 | 121.93 | +1.34% | |
Microsoft | US5949181045 | 2.41 | 412.87 | -0.43% | |
Thermo Fisher Scientific | US8835561023 | 2.33 | 516.10 | +0.64% | |
Newmont Goldcorp | US6516391066 | 2.24 | 43.32 | +0.77% | |
Bristol-Myers Squibb | US1101221083 | 2.05 | 58.23 | +0.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pioneer Zrownowazony | 644.1M | 18.66 | 7.63 | 1.12 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review